Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

Background Intratumorally delivered immunotherapies have the potential to favorably alter the local tumor microenvironment and may stimulate systemic host immunity, offering an alternative or adjunct to other local and systemic treatments. Despite their potential, these therapies have had limited su...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Bart Neyns, Mark Middleton, Aurélien Marabelle, Ignacio Melero, Ke Liu, Nina Bhardwaj, Tanja D de Gruijl, Jason Chesney, Robert Coffin, Howard Kaufman, Diwakar Davar, Jason J Luke, Georgina V Long, Kevin J Harrington, Sherene Loi, Thierry de Baere, David J Pinato, Matthew Fury, Ciara M Kelly, Joshua D Brody, Robert H Andtbacka, Gregory Goldmacher, Anuradha D Khilnani, Rahul A Sheth, Stephen B Solomon, Philippe Szapary
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMJ Publishing Group 2024-04-01
Sarja:	Journal for ImmunoTherapy of Cancer
Linkit:	https://jitc.bmj.com/content/12/4/e008378.full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!